International Journal of Endocrinology and Metabolism

Published by: Kowsar

Prevalence of Lipohypertrophy and Associated Risk Factors in Insulin-Treated Patients With Type 2 Diabetes Mellitus

Mo’men Al Ajlouni 1 , Mousa Abujbara 2 , Anwar Batieha 3 and Kamel Ajlouni 2 , *
Authors Information
1 Prince Sultan Military Medical, Riyadh, Saudi Arabia
2 The National Center for Diabetes, Endocrinology and Genetics, Amman, Jordan
3 Department of Community Medicine and Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
Article information
  • International Journal of Endocrinology and Metabolism: April 01, 2015, 13 (2); e20776
  • Published Online: April 30, 2015
  • Article Type: Research Article
  • Received: July 1, 2014
  • Revised: September 27, 2014
  • Accepted: December 2, 2014
  • DOI: 10.5812/ijem.20776

To Cite: Al Ajlouni M, Abujbara M, Batieha A, Ajlouni K. Prevalence of Lipohypertrophy and Associated Risk Factors in Insulin-Treated Patients With Type 2 Diabetes Mellitus, Int J Endocrinol Metab. 2015 ; 13(2):e20776. doi: 10.5812/ijem.20776.

Copyright © 2015, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131): 837-53[PubMed]
  • 2. Fujikura J, Fujimoto M, Yasue S, Noguchi M, Masuzaki H, Hosoda K, et al. Insulin-induced lipohypertrophy: report of a case with histopathology. Endocr J. 2005; 52(5): 623-8[PubMed]
  • 3. Seyoum B, Abdulkadir J. Systematic inspection of insulin injection sites for local complications related to incorrect injection technique. Trop Doct. 1996; 26(4): 159-61[PubMed]
  • 4. Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003; 4(10): 661-7[PubMed]
  • 5. Hauner H, Stockamp B, Haastert B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp Clin Endocrinol Diabetes. 1996; 104(2): 106-10[DOI][PubMed]
  • 6. Blanco M, Hernandez MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013; 39(5): 445-53[DOI][PubMed]
  • 7. Carr DB, Utzschneider KM, Hull r. l. , Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes Metab. 1996; 53: 2087-94
  • 8. American Diabetes A. Standards of medical care in diabetes--2011. Diabetes Care. 2011; 34 Suppl 1-61[DOI][PubMed]
  • 9. Kasha Z, Haiheydan Z, Akha O, Akbarzadeh S. Prevalence of lipodystrophy associated with recombinant insulin. Mazandaran Uni Med Sci J. 2008; 18: 9
  • 10. Chowdhury TA, Escudier V. Poor glycaemic control caused by insulin induced lipohypertrophy. BMJ. 2003; 327(7411): 383-4[DOI][PubMed]
  • 11. Hambridge K. The management of lipohypertrophy in diabetes care. Br J Nurs. 2007; 16(9): 520-4[DOI][PubMed]
  • 12. Sea-de Ibarra L, Gallego F. Factors related to Lipohypertrophy in insulin-treated diabetic patients: role of educational intervention. Practical Diab Int. 1998; 15(1): 9–11
  • 13. Malwa G, Balami D, Deshmukh S, Groft M, Bodmer C, Patel M. Insulin-induced Lipohypertrophy, past present and future: are we lose the bottle. Endocrine. 2010; 22: 268
  • 14. Vardar B, Kizilci S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract. 2007; 77(2): 231-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments